![](/img/cover-not-exists.png)
Phase II study of gefitinib in combination with paclitaxel (P) and carboplatin (C) as second-line therapy for ovarian, tubal or peritoneal adenocarcinoma (1839IL/0074)
Patricia Pautier, Florence Joly, Pierre Kerbrat, Philippe Bougnoux, Pierre Fumoleau, Thierry Petit, Olivier Rixe, François Ringeisen, Annie Tisseron Carrasco, Catherine LhomméVolume:
116
Year:
2010
Language:
english
Pages:
6
DOI:
10.1016/j.ygyno.2009.10.076
File:
PDF, 283 KB
english, 2010